Abstract
It has been long recognized that radiotherapy, surgery, and chemotherapy for head and neck (H&N) cancer cause a wide range of acute and late morbidities. These effects impact general and H&N-specific symptoms, quality of life, and critical functions. The increasing use of altered fractionation and chemoradiation has led to a substantial increase in both acute and late toxicity. Countering this is the growing use of intensity-modulated radiation which has lowered dry mouth-related issues and targeted agents which are associated with less complex/lower burden toxicity profiles. In this chapter, we discuss issues in toxicity measures and reporting methods. We also discuss the management of mucositis, swallowing disorders, and osteonecrosis.
Original language | English (US) |
---|---|
Title of host publication | Head and Neck Cancer |
Subtitle of host publication | Multimodality Management, Second Edition |
Publisher | Springer International Publishing |
Pages | 753-767 |
Number of pages | 15 |
ISBN (Electronic) | 9783319276014 |
ISBN (Print) | 9783319275994 |
DOIs | |
State | Published - Jan 1 2016 |
Keywords
- Adverse effects
- Adverse events
- CTCAE
- Complications
- Morbidity
- Quality of life
- Side effects
- Toxicity
ASJC Scopus subject areas
- General Medicine